Fukushima N
Hokkaido Igaku Zasshi. 1975 Jul;50(4):369-85.
Changes in rectal and skin temperatures following intraventricular injection of biogenic amines and related substances were investigated in rats. Intraventricular injection of norepinephrine in a small dose (6 mug) produced a slight elevation of rectal temperature, but in larger amounts (25-50 mug) resulted in a dose-dependent hypothermia which was associated with a marked rise of skin temperature. No change was observed in plasma free fatty acid and glucose levels and oxygen consumption after intraventricular injection of norepinephrine (25 mug). Intraventricular injection of imipramine and safrazine produced a slight fall in the rectal temperature. Norepinephrine-induced hypothermia was more pronounced in rats pretreated with safrazine and less in rats pretreated with alpha-methyl-p-tyrosine, as compared with that in controls. Intraventricular injection of 6-hydroxydopamine (0.75-250 mug) brought about a marked dose-dependent hypothermia. The second injection of 6-hydroxydopamine 5 days after the first injection had no effect on the body temperature. Norepinephrine injection 2 days after the second injection of 6-hydroxydopamine produced a more pronounced hypothermia than the change in control rats without pretreatments. Haloperidol did not affect the hypothermia induced by 6-hydroxydopamine. Intraventricular injection of dopamine and L-DOPA showed less effect that norepinephrine had. Intraventricular injection of phenoxybenzamine prior to norepinephrine blocked the hypothermia and skin temperature elevation which are normally observed following norepinephrine injection, while propranolol given in the same way showed less or no effect. Intraventricular injection of phenylephrine produced a dose-dependent hypothermia, whereas no dose-response relationship was obtained by isoproterenol. These results suggest that in the rat the hypothermic effect of norepinephrine injected intraventricularly is mediated by an action of central alpha-receptor. At high and low ambient temperatures hypothermia was similarly observed following intraventricular injection of 5-hydroxytryptamine (25 mug) as at normal room temperature. On the other hand, norepinephrine (25 mug) produced a rise in rectal temperature at high ambient temperature and a marked fall at low ambient temperature. The hypothermic effect of norepinephrine was not different between cold-adapted ones at room temperature. From the results the role of norepinephrine and other biogenic amines in the brain in thermoregulatory processes was discussed.
研究了向大鼠脑室内注射生物胺及相关物质后直肠温度和皮肤温度的变化。向脑室内注射小剂量(6微克)去甲肾上腺素会使直肠温度略有升高,但注射较大剂量(25 - 50微克)则会导致剂量依赖性体温过低,同时皮肤温度显著升高。脑室内注射去甲肾上腺素(25微克)后,血浆游离脂肪酸、葡萄糖水平及氧耗未见变化。脑室内注射丙咪嗪和沙夫拉嗪会使直肠温度略有下降。与对照组相比,沙夫拉嗪预处理的大鼠去甲肾上腺素诱导的体温过低更明显,而α-甲基-对-酪氨酸预处理的大鼠则较轻。脑室内注射6-羟基多巴胺(0.75 - 250微克)会引起明显的剂量依赖性体温过低。首次注射后5天再次注射6-羟基多巴胺对体温无影响。第二次注射6-羟基多巴胺2天后注射去甲肾上腺素,与未预处理的对照大鼠相比,体温过低更明显。氟哌啶醇不影响6-羟基多巴胺诱导体温过低。脑室内注射多巴胺和左旋多巴的作用比去甲肾上腺素小。去甲肾上腺素注射前脑室内注射酚苄明可阻断去甲肾上腺素注射后通常出现的体温过低和皮肤温度升高,而以同样方式给予普萘洛尔则作用较小或无作用。脑室内注射去氧肾上腺素会产生剂量依赖性体温过低,而异丙肾上腺素未得到剂量-反应关系。这些结果表明,在大鼠中,脑室内注射去甲肾上腺素的体温过低效应是由中枢α受体的作用介导的。在高、低环境温度下,脑室内注射5-羟色胺(25微克)与在正常室温下一样会出现体温过低。另一方面,去甲肾上腺素(25微克)在高环境温度下会使直肠温度升高,在低环境温度下则会显著下降。在室温下,去甲肾上腺素对冷适应大鼠的体温过低效应无差异。根据这些结果,讨论了脑中去甲肾上腺素和其他生物胺在体温调节过程中的作用。